News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
O'Day Daniel Patrick
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 3,409 shares
@ $78.12, valued at
$266.3k
Exercised 7,346 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 14,017 shares
@ $79.5, valued at
$1.1M
Exercised 19,488 restricted stock units
@ $0
Exercised 10,800 restricted stock units
@ $0
Granted 47,170 restricted stock units
@ $0
Granted 215,095 options to buy
@ $79.5, valued at
$17.1M
|
|
| 03/02/2023 |
4
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 4,842 shares
@ $79.59, valued at
$385.4k
Exercised 11,362 restricted stock units
@ $0 |
|
| 01/26/2023 |
4
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 78,370 shares
@ $0
Granted 136,647 shares
@ $0
Paid exercise price by delivering 59,078 shares
@ $84.02, valued at
$5M
|
|
| 12/13/2022 |
4
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 1,542 shares
@ $87.97, valued at
$135.6k
Exercised 3,300 restricted stock units
@ $0 |
|
| 09/12/2022 |
4
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 1,528 shares
@ $65.28, valued at
$99.7k
Exercised 3,301 restricted stock units
@ $0 |
|
| 06/13/2022 |
4
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 1,539 shares
@ $60.74, valued at
$93.5k
Exercised 3,300 restricted stock units
@ $0 |
|
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 64,008 shares
@ $0
Granted 82,670 shares
@ $0
Paid exercise price by delivering 33,833 shares
@ $67.34, valued at
$2.3M
|
|
| 03/31/2021 |
4/A
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Paid exercise price by delivering 5,123 shares
@ $63.91, valued at
$327.4k
Granted 52,810 restricted stock units
@ $0
Granted 307,355 options to buy
@ $63.91, valued at
$19.6M
Exercised 10,800 restricted stock units
@ $0 |
|
| 03/12/2021 |
4
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Paid exercise price by delivering 5,123 shares
@ $63.91, valued at
$327.4k
Granted 52,810 restricted stock units
@ $0
Granted 307,355 options to buy
@ $63.91, valued at
$19.6M
Exercised 10,800 restricted stock units
@ $0 |
|
| 03/03/2021 |
4
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Paid exercise price by delivering 24,620 shares
@ $62.46, valued at
$1.5M
Exercised 42,923 restricted stock units
@ $0
Exercised 11,363 restricted stock units
@ $0 |
|
| 01/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2020 |
4
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 19,204 shares
@ $0 |
|
| 03/05/2019 |
4
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 231,280 options to buy
@ $66.01, valued at
$15.3M
Granted 45,450 restricted stock units
@ $0
Granted 128,770 restricted stock units
@ $0 |
|
| 03/01/2019 |
3
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 3 on GILEAD SCIENCES INC |
|
|